Live feed07:30:00·31dPRReleasevia QuantisnowVertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United StatesByQuantisnow·Wall Street's wire, on your screen.VRTX· Vertex Pharmaceuticals IncorporatedHealth Care
